Filing Details
- Accession Number:
- 0000874716-23-000103
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-08-07 17:04:57
- Reporting Period:
- 2023-08-03
- Accepted Time:
- 2023-08-07 17:04:57
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 874716 | Idexx Laboratories Inc | IDXX | In Vitro & In Vivo Diagnostic Substances (2835) | 010393723 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1740689 | Michael Lane | One Idexx Drive Westbrook ME 04092 | Executive Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2023-08-03 | 1,512 | $141.60 | 5,546 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-08-03 | 7,435 | $178.26 | 12,981 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2023-08-03 | 7,080 | $206.94 | 20,061 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2023-08-03 | 16,027 | $510.00 | 4,034 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Incentive Stock Option (right-to-buy) | Disposition | 2023-08-03 | 1,512 | $0.00 | 1,512 | $141.60 |
| Common Stock | Incentive Stock Option (right-to-buy) | Disposition | 2023-08-03 | 7,435 | $0.00 | 7,435 | $178.26 |
| Common Stock | Incentive Stock Option (right-to-buy) | Disposition | 2023-08-03 | 7,080 | $0.00 | 7,080 | $206.94 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2027-02-13 | No | 4 | M | Direct | |
| 0 | 2028-02-13 | No | 4 | M | Direct | |
| 1,286 | 2029-02-13 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 592 | Indirect | by spouse |
Footnotes
- Includes 12 shares purchased under the Issuer's Employee Stock Purchase Plan on June 30, 2023.
- Represents the weighted average price of the shares sold ranging from a low of $510.00 to a high of $510.10 per share. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares purchased at each separate price.
- Held by spouse in an IRA account. The reporting person disclaims beneficial ownership of the shares of common stock held by his spouse except to the extent of his pecuniary interest therein.
- Grant of option to buy 10,386 shares of Issuer common stock that vested in five annual installments beginning February 14, 2018.
- Grant of option to buy 9,434 shares of Issuer common stock that vested in five annual installments beginning February 14, 2019.
- Grant of option to buy 8,366 shares of Issuer common stock that vested in five annual installments beginning February 14, 2020.
Billionaire Hedge Funds
